Zolmitriptan induced acute coronary syndrome: A unique case

American Journal of Therapeutics

Volumn 18, Issue 5, 2011, Pages

  Smith, Marcus ^a   Golwala, Harsh ^a   Lozano, Pedro ^a  

^a UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

Author keywords

acute coronary syndrome; coronary vasospasm; zolmitriptan

Indexed keywords

ACETYLSALICYLIC ACID; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CREATINE KINASE MB; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCERYL TRINITRATE; HEPARIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN; ZOLMITRIPTAN;

ACUTE CORONARY SYNDROME; ADULT; ANAMNESIS; ANGIOCARDIOGRAPHY; ARTICLE; CASE REPORT; CORONARY ARTERY SPASM; ELECTROCARDIOGRAPHY; HUMAN; HYPERTENSION; HYPOKINESIA; MALE; MIGRAINE; NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; RIGHT CORONARY ARTERY; SMOKING CESSATION; ST SEGMENT DEPRESSION; T WAVE; THORAX PAIN; TRANSTHORACIC ECHOCARDIOGRAPHY;

ACUTE CORONARY SYNDROME; CHEST PAIN; ELECTROCARDIOGRAPHY; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; MYOCARDIAL INFARCTION; NITROGLYCERIN; OXAZOLIDINONES; SEROTONIN 5-HT1 RECEPTOR AGONISTS; TRYPTAMINES; VASODILATOR AGENTS;

EID: 80052700217     PISSN: 10752765     EISSN: 15363686     Source Type: Journal    
DOI: 10.1097/MJT.0b013e3182258e2e     Document Type: Article

References (16)

1. MaassenVanDenBrink A, Reekers M, Bax WA, et al. Coronary side-effect potential of current and prospective antimigraine drugs. Circulation. 1998;98:25-30. (Pubitemid 28312075)
2. MacIntyre PD, Bhargava B, Hogg KJ, et al. Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation. Circulation. 1993;87:401-405. (Pubitemid 23040908)
3. Dodick D, Lipton RB, Martin V, et al. Consensus statement: cardiovascular safety profile of triptans (5-HT agonists) in the acute treatment of migraine. Headache. 2004;44:414-425. (Pubitemid 38685549)
4. Anghileri E, Toso V, Perini F. Acute myocardial infarction after sumatriptan administration for cluster headache. Neurol Sci. 2006;26:456-459.
5. Erbilen E, Ozhan H, Akdemir R, et al. A case of myocardial infarction with sumatriptan use. Pediatr Cardiol. 2005;26: 464-466. (Pubitemid 43004599)
6. Hack JB. Oral sumatriptan-induced myocardial infarction. J Toxicol Clin Toxicol. 2004;42:309-311. (Pubitemid 39166759)
7. Hadjiloizou N, Rakhit R. Frovatriptan, a probable cause of coronary vasoconstriction. Int J Clin Pract. 2008;62: 1121-1122. (Pubitemid 351793607)
8. Kelly KM. Cardiac arrest following use of sumatriptan. Neurology. 1995;45:1211-1213.
9. Liston H, Bennett L, Usher B Jr, et al. The association of the combination of sumatriptan and methysergide in myocardial infarction in a premenopausal woman. Arch Intern Med. 1999;159:511-513. (Pubitemid 29108918)
10. Mikhail GW, Airoldi F, Colombo A. Acute myocardial infarction following the use of antimigraine therapy. J Invasive Cardiol. 2004;16:602-603. (Pubitemid 40731721)
11. Mueller L, Gallagher RM, Ciervo CA. Vasospasm-induced myocardial infarction with sumatriptan. Headache. 1996; 36:329-331. (Pubitemid 26162559)
12. O'Connor P, Gladstone P. Oral sumatriptan-associated transmural myocardial infarction. Neurology. 1995;45: 2274-2276. (Pubitemid 27100262)
13. Pacheco-Coronado R, McMullan PW, Galbut BH, et al. Myocardial infarction after taking zolmitriptan. Yale J Biol Med. 2005;78:147-150.
14. Weder CR, Schneemann M. Triptans and troponin: a case report. Orphanet J Rare Dis. 2009;4:15.
15. Weir RA, Oldroyd KG,Walters MR. Myocardial infarction after oral sumatriptan use in a woman with normal coronary arteries. Am J Med. 2007;120:e7-e8. (Pubitemid 47633482)
16. Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239-245. (Pubitemid 12149145)